RefleXion

25841 Industrial Blvd
#275
Hayward
California
94545
United States

Fax: (650) 239-9070

About RefleXion

RefleXion is a privately held therapeutic oncology company located in Hayward, Calif., transforming radiopharmaceuticals from diagnosing cancer to actively controlling delivery of external-beam radiotherapy by leveraging individual tumor biology. Designated an FDA Breakthrough Device, RefleXion’s SCINTIX™ biology-guided radiotherapy automates targeting and motion management to overcome long-standing barriers preventing definitive radiotherapy for metastatic disease. In strategic collaborations with radiopharmaceutical companies, RefleXion is co-developing and co-commercializing disease-specific radiopharmaceuticals for difficult to treat late-stage cancers. RefleXion’s vision is to extend the established safety, efficacy and cost-effectiveness of external-beam radiotherapy to patients with solid tumor malignancies of any stage.

CONNECT

The RefleXion® X1 with SCINTIX™ technology marries PET and CT, proven modalities for visualizing cancer, with radiotherapy, one of the most effective ways of treating cancer, in a dual-treatment modality platform.

31 articles about RefleXion

RefleXion Raises $100 Million for Cancer Treatment Commercialization

4/16/2020

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of a $100 million equity financing led by Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers that focuses on long-term investments with partners demonstrating strong value orientation strategies.
RefleXion Achieves Key Milestone with Grand Opening of Manufacturing Facility

5/9/2019

RefleXion Medical, a biotargeting oncology company using each cancer’s unique biology as a means to destroy it, today announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif.
RefleXion Adds Manufacturing Space, 50 Employees as it Prepares for Launch of Radiotherapy System

5/8/2019

RefleXion will open a 50,000-square-foot manufacturing site later this month and add 50 employees by the end of the year.
Oxford Finance Closes $60 Million Credit Facility with Oncology Innovator RefleXion Medical

5/1/2019

The funds will support the completion of the FDA clearance process for their biology-guided BgRT system and its subsequent commercial launch.
RefleXion Medical Announces Five Key Hires to Executive Team

10/15/2018

Martyn Webster joins as CFO; Sean Shirvani, MD, joins as VP of Medical Affairs; Judy Bartlett-Roberto joins as VP of Marketing; Partha Ray joins as VP of Innovation Strategy; Len Lyons joins as VP of Sales
Reflexion Health Launches the Next-Generation of its Virtual Exercise Rehabilitation Assistant (VERA), Further Enhancing the Physical Therapy Experience For Patients and Clinicians

3/22/2018

VERAHome and VERAClinic leverage avatar-led educational content, 3-D imaging with real-time feedback, and personalized care interventions to make recovery at home more engaging and more convenient than ever before
RefleXion Chooses MedCrypt To Provide Medical Device Security For First-To-Market Radiotherapy Technology

9/25/2017
RefleXion Extends Series B Financing to $52 Million With Help From Johnson & Johnson

7/19/2016
Bay Area's Reflexion Medical Raises $46 Million Series B Financing

4/15/2016
Reflexion Medical Names Frederic H. Moll To Its Board Of Directors

1/20/2016
Bay Area Device Firm Reflexion Medical Secures $11.6 Million

4/4/2014